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Tau blocks trafﬁc of organelles, neuroﬁlaments, and 
APP vesicles in neurons and enhances oxidative stress
 
K. Stamer, R. Vogel, E. Thies, E. Mandelkow, and E.-M. Mandelkow
 
Max-Planck-Unit for Structural Molecular Biology, 22607 Hamburg, Germany
 
e studied the effect of microtubule-associated tau
protein on trafﬁcking of vesicles and organelles
in primary cortical neurons, retinal ganglion cells,
and neuroblastoma cells. Tau inhibits kinesin-dependent
transport of peroxisomes, neuroﬁlaments, and Golgi-derived
vesicles into neurites. Loss of peroxisomes makes cells
vulnerable to oxidative stress and leads to degeneration. In
particular, tau inhibits transport of amyloid precursor protein
(APP) into axons and dendrites, causing its accumulation in
W
 
the cell body. APP tagged with yellow ﬂuorescent protein
and transfected by adenovirus associates with vesicles
moving rapidly forward in the axon (
 
 
 
80%) and slowly
back (
 
 
 
20%). Both movements are strongly inhibited by
cotransfection with ﬂuorescently tagged tau (cyan ﬂuorescent
protein–tau) as seen by two-color confocal microscopy.
The data suggests a linkage between tau and APP trafﬁcking,
which may be signiﬁcant in Alzheimer’s disease.
 
Introduction
 
Tau protein, a neuronal microtubule-associated protein
(MAP),* is known for its role in the stabilization of micro-
tubules, which is important for the generation and maintenance
of neurites (Cleveland et al., 1977; Binder et al., 1985; Drubin
and Kirschner, 1986; Caceres and Kosik, 1990). In Alzheimer’s
disease, tau accumulates in neurons, aggregates into paired
helical filaments, and loses its microtubule-binding and stabi-
lizing function, leading to the degeneration of neurons (Garcia
and Cleveland, 2001). Besides the role in microtubule
stabilization, tau has other functions, such as membrane
interactions or anchoring of enzymes (Brandt et al., 1995;
Lee et al., 1998; Liao et al., 1998; Sontag et al., 1999). A
further recently discovered function of tau is its ability to
inhibit the transport of cell components in cultured fibroblasts.
This may lead to the gradual retraction of mitochondria
toward the cell center where the minus ends of microtubules
are anchored. A similar behavior is observed for the ER and
intermediate filaments. These effects can be explained by an
interference between tau and motors, leading to a preferential
inhibition of kinesin-like motors, which are responsible for
transport towards the cell periphery (Ebneth et al., 1998). If
such effects of tau on intracellular transport also took place in
Alzheimer’s disease neurons, one might expect a shortage of
mitochondria and peroxisomes in cell processes with a
concomitant loss of energy production and accumulation of
reactive oxygen species. In addition, the anterograde transport
of vesicles necessary for growth cones and synapse function
might be slowed down. With these questions in mind, we
studied neuron-like cell models (N2a neuroblastoma),
cultured primary cortical neurons from rats or mice, and
chicken retinal ganglion cells (RGCs) for the effects of tau
overexpression. We show that these cells have an intact
microtubule network, but their processes are deficient in
mitochondria or peroxisomes, their growth is retarded, and
they are highly sensitive to oxidative stress. Neurofilament
protein accumulates in the cell body rather than distributing
along the processes, reminiscent of ALS-like symptoms in
tau-expressing transgenic mice (Ishihara et al., 1999, 2001;
Götz et al., 2001; Lewis et al., 2001). In addition, the trans-
port of Golgi-derived vesicles into axons is inhibited. Nota-
bly, vesicles carrying the amyloid precursor protein (APP) are
retained in the cell body, which would allow an enhanced
 
production of toxic A
 
 
 
 peptides (Xu et al., 1997). Since tau
may be increased in Alzheimer’s disease neurons (Khatoon et
al., 1992), these observations could provide a link to patho-
logical features observed in Alzheimer’s disease, such as oxi-
dative stress, impaired energy supply, loss of intracellular
transport, or altered processing of APP.
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Results
 
Tau inhibits the transport of peroxisomes, 
neurofilaments, and vesicles along neurites
 
Upon differentiation with retinoic acid, N2a cells develop
neurites, which grow to typical lengths of 30 
 
 
 
m after 2 d.
The neurites contain the components necessary for sustained
growth, such as mitochondria for the generation of chemical
energy, peroxisomes for detoxification of H
 
2
 
O
 
2
 
, neurofila-
ments and microtubules for structural stability and intracel-
lular transport, and transport vesicles carrying supplies for
the growth cone (Figs. 1 and 2). N2a cells contain only a low
concentration of endogenous tau hardly visible by immuno-
fluorescence and are therefore useful models for testing the
consequences of enhanced tau expression. Its effect on perox-
isomes is illustrated in Fig. 1 A; these organelles are normally
distributed throughout the cell body and neurites, but in
cells with elevated tau they are virtually absent from the neu-
rites, become clustered in the cell center around the microtu-
bule organizing center (MTOC), and the neurites are inhib-
ited in their growth (Fig. 1 A). In contrast, microtubules, the
tracks of transport, are present throughout the neurites. An
analogous behavior is observed with Golgi-derived vesicles
visualized by WGA (Fig. 1 B): in normal N2a cells, they are
visible in the cell body (mostly around the Golgi apparatus)
and along the extended neurites (Fig. 1 B), but in cells with
elevated tau they are strongly reduced in neurites and instead
are concentrated in the Golgi area. Likewise, neurofilaments
and mitochondria, which are normally present in neurites
(Fig. 1 D), become clustered around the MTOC and Golgi
area where microtubules originate. In all examples, microtu-
bules and associated proteins such as tau are still capable of
Figure 1. Tau causes the disappearance 
of vesicles and organelles from neurites. 
(A) Peroxisomes: N2a cells were 
differentiated for 2 d by 1  M retinoic 
acid, fixed in methanol, and 
immunostained for peroxisomes (left) and 
tubulin (right). In mock-transfected 
controls (top), peroxisomes and MTs are 
visible in the cell body and throughout 
the neurite. In cells stably expressing tau 
(bottom), peroxisomes are mostly absent 
from the neurites and clustered around 
the MTOC in the cell body. These cells 
also have shorter neurites than the 
controls, but microtubules are still 
present throughout the neurites. (B) 
WGA-labeled vesicles: similar 
experiment as in A but staining with 
rhodamine-labeled WGA (left). In 
mock-transfected cells (top), WGA-stained 
vesicles (presumably Golgi-derived 
[Gonatas and Avrameas, 1977]) are 
visible in the cell body and neurite (inset, 
proximal neurite). In tau stable cells 
(bottom), the vesicles are strongly reduced 
in the neurites, and the trans-Golgi 
network is more contracted in the cell 
body. (C) Quantitation of the number of 
peroxisomes (left) and Golgi-derived 
vesicles (right) in neurites of N2a cells
derived from 20- m stretches of proximal 
neurites. In tau-stable cells, the density of 
peroxisomes decreases to  6% of the 
control cells, and the density of vesicles 
decreases to  25% of the control. (D) 
Disappearance of neurofilaments and
mitochondria from neurites of
tau-expressing N2a cells. In control N2a 
cells (top), neurofilaments (left, stained by 
antibody SMI32) and mitochondria 
(center, stained by MitoTracker Red) both 
extend along the entire length of the 
neurite, whereas tau (right, stained by
antibody K9JA) is not visible in the cells 
because its endogenous concentration is 
too low. In tau-stable cells (bottom), 
neurofilaments and mitochondria are 
strongly reduced in the neurite and 
clustered in the cell body, whereas tau is 
visible in both compartments. 
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spreading throughout the neurite, both in control cells and
at elevated tau concentrations. This means that the tracks for
intracellular transport are laid out in the neurite, but the
transport along them is severely impaired.
The quantitation of the density of organelles in neurites
revealed a dramatic 17-fold decrease of peroxisomes in tau-
transfected cells compared with controls (Fig. 1 C, left). The
concentration of Golgi-derived vesicles in neurites also de-
creased strongly (about fourfold) (Fig. 1 C, right); in this
case, the decrease was not as pronounced as for peroxisomes,
presumably because of the higher diffusional mobility of ves-
icles, which makes them less dependent on active transport.
For mitochondria, the results were comparable to peroxi-
somes, that is, nearly complete disappearance from neurites
(Fig. 1 D, bottom). It implies that neurites lack the energy
of ATP (because of the missing mitochondria) and lack pro-
tection against oxidative stress (because of the missing perox-
isomes), both of which would explain why tau-expressing
cells have fewer and shorter neurites (see below).
 
Elevation of tau causes transport defects in primary 
neuronal cells
 
Since N2a is a neuroblastoma cell line, we wanted to test if
primary neurons would show a similar behavior when tau is
increased. Hippocampal neurons were prepared from the
cortices of rats or mice (following Banker and Goslin, 1998)
and transfected with tau by three different methods, by her-
pes simplex virus (HSV) or adenovirus (AV) vectors contain-
ing the longest human tau isoform (htau40) or by the cal-
cium phosphate method (Fig. 2). The transfected tau was
detected by the enhanced immunofluorescence of an anti-
body against human tau (Fig. 2 A, bottom right) or by an
antibody against the HA tag on tau. In control rat primary
neurons, mitochondria were spread throughout the cell
body and the cell processes (Fig. 2 A, top left). However,
when cells were transfected with tau by either method mito-
chondria disappeared from the neurites and became con-
centrated in the cell body (Fig. 2 A, bottom left). Cells
transfected by the vector only did not show an effect
(unpublished data). At 16 h after transfection, the average
number of mitochondria found in the initial 50 
 
 
 
m of the
cell process decreased threefold (Fig. 2 B, left), and the de-
crease was even more marked further toward the growth
cone. Similar observations were made with peroxisomes
(Fig. 2 B, right). This means that the elevation of tau has
similar effects on intracellular transport in primary neurons,
neuron-like cell models, or nonneuronal cells, that is, the
preferential inhibition of plus-end–directed transport by ki-
nesin motors along microtubules so that minus-end–directed
transport by a dynein-like motor becomes dominant.
 
Tau expression makes neurites 
vulnerable against stress
 
Since the depletion of organelles from the neurites in cells
with elevated tau would be expected to make them more vul-
nerable, we tested their susceptibility against oxidative stress.
Fig. 3 illustrates the reaction of differentiated N2a cells
against 250 
 
 
 
M H
 
2
 
O
 
2
 
. This leads to a gradual loss of cell
processes and eventually to cell death (Fig. 3 A). However, in
tau-transfected cells the degradation of neurites is much
more rapid (Fig. 3 A, bottom), and long neurites are more
vulnerable than short ones. This was quantitated separately
for long (
 
 
 
30 
 
 
 
m) neurites where the decay was noticeable
already at lower H
 
2
 
O
 
2
 
 and shorter times (Fig. 3 B). Starting
from a cell population differentiated for 2 d where 12.3% of
the cells contained a long neurite, 150 
 
 
 
M H
 
2
 
O
 
2
 
 caused a
loss of half the long neurites (down to 5.9%) (Fig. 3 B, third
bar) in the control cells within 40 min. Tau-expressing cells
Figure 2. Axons of primary rat neurons transfected 
by HSV-tau become depleted of mitochondria. (A, 
top) Rat primary hippocampal neurons contain
mitochondria (left, stained with MitoTracker Red) and 
endogenous tau (right, stained with antibody KJ9A) in 
the cell body and neurites. (A, bottom) When primary 
neurons are treated with an HSV vector containing 
htau40 (transfection rate 75%), the positive cells are 
strongly stained with the tau antibody (bottom right), 
and mitochondria largely disappear from the neurites 
(bottom left, arrowhead). (B) Quantitation of 
mitochondria (left) and peroxisomes (right) measured 
in the proximal 50  m of the neurite. The number of 
mitochondria decreases approximately  3-fold in 
tau-transfected cells compared with controls, and 
peroxisomes decrease  2.5-fold. The decrease of 
organelles is even more pronounced in the more distal 
parts of the neurites. Error bars show SEM; n   10.  
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had somewhat fewer long neurites to begin with (9.9%), but
the loss upon exposure to H
 
2
 
O
 
2
 
 was much more dramatic
(33-fold, down to 0.3%) (Fig. 3 B, seventh bar). This could
be explained by the depletion of peroxisomes containing cat-
alase for the detoxification of H
 
2
 
O
 
2
 
. We added catalase (0.02
U/
 
 
 
l) to the medium to check that the degeneration effect
was due to the extracellular added hydrogen peroxide. Cata-
lase alone had no effect on the survival of neurites (Fig. 3 B,
second and sixth bar), but when challenging the cells with
H
 
2
 
O
 
2
 
 and then immediately adding the catalase it provided
an efficient protection (Fig. 3 B, fourth and eighth bars).
To corroborate these findings, we next tested the effect of
inhibiting directly the endogenous catalase contained in the
peroxisomes using the inhibitor 3-aminotriazole (3-AT).
Among the population of mock-transfected N2a cells shown
in Fig. 3 C, initially 11.5% contained long neurites. This
value dropped to about half (5.2%) after exposure to 150 
 
 
 
M
H
 
2
 
O
 
2
 
 for 40 min (Fig. 3 C, third bar). The decay became
even more pronounced after pretreatment with 10 mM 3-AT
(down to 2.7%) (Fig. 3 C, fourth bar), whereas 3-AT alone
without H
 
2
 
O
 
2
 
 had only a moderate effect (decay to 9.0%)
(Fig. 3 C, second bar). In tau-overexpressing N2a cells, H
 
2
 
O
 
2
 
strongly reduced the number of neurites (from 8.4 to 0.7%)
(Fig. 3 C, fifth compared with seventh bar), but in this case
there was no further reduction by 3-AT (Fig. 3 C, eighth bar).
The experiment illustrates that the inhibition of catalase exac-
erbates the oxidative damage induced by H
 
2
 
O
 
2 
 
but only if per-
oxisomes are present in the neurites. However, if they are de-
pleted from the neurites by overexpression of tau the catalase
inhibitor 3-AT has no target and thus no further effect. (Note
that we disregard here, in first approximation, the diffusion of
H
 
2
 
O
 
2
 
 between the neurites and the cell body where peroxi-
somes are concentrated in the tau-transfected cells because we
are scoring only long neurites, and we also disregard the small
contribution of cytosolic catalase.)
One concern in interpreting these results is that tau expres-
sion might have a negative effect on cell viability or the cell’s ca-
pacity for detoxification, independently of tau’s effect on trans-
port after differentiation. In other words, elevated tau might
somehow be toxic for the cell independently of its state of dif-
ferentiation. Therefore, as a control the survival of undifferenti-
ated N2a cells was checked by the 3-(4,5-dimethylthiazol-2yl)-
Figure 3. Neurites of N2a cells 
overexpressing tau are highly susceptible 
to oxidative stress. (A, top) Control N2a 
cells (mock-transfected with vector) 
differentiated for 2 d and exposed to 250 
 M H2O2 for up to 2 h. At 60 min, long 
neurites ( 30  m) stained for 
microtubules are less frequent but still 
clearly visible, and even at 120 min 
some thin neurites can be discerned. (A, 
bottom) Tau-stable N2a cells treated 
with H2O2. Neurites ( 30  m) disappear 
quickly and are no longer visible at 60 
min. (B) Quantitation of oxidative stress 
by H2O2 and protection by catalase. 
Differentiated N2a cells (2 d) were treated 
with 30  M H2O2, and neurites longer 
than 30  m (twice the cell body diameter) 
were scored. In mock-transfected cells 
(left group of bars), the fraction of cells 
with long neurites drops from an initial 
value of 12.3 to 5.9% (  2-fold) after 40 
min of H2O2. In tau-transfected cells, 
(right group of bars) this fraction drops 
from an initial 9.9% down to 0.3% 
( 33-fold). Adding catalase (0.02 U/ l) 
but no H2O2 to the medium does not 
change the number of long neurites 
(black bars). When catalase is added
immediately after H2O2 exposure in 
control cells, it protects the cells so that 
8.7% still have long neurites after 40 
min H2O2 treatment compared with only 
5.9% without catalase. In the case of 
tau-overexpressing cells, the fraction of cells with long neurites drops from 9.9 to 0.3% after H2O2 treatment but only to 5.6% with catalase. 
Thus, the higher vulnerability of neurites in tau-expressing cells can be explained by the lack of peroxisomes carrying catalase. Experiments 
were done in triplicate, 3   150 cells were counted for each condition. Error bars show SEM. (C) Inhibition of catalase exacerbates vulnerability 
of neurites against H2O2 in controls but not in tau-transfected cells. (Left) Mock-transfected cells differentiated for 2 d: the fraction of cells 
with long neurites ( 30  m) drops from 11.5% (untreated) to 5.2% after H2O2 treatment (30  M, 40 min). Inhibition of catalase with 10 mM 
3-AT for 60 min causes some degeneration (to 9.0%), but treatment first with 10 mM 3-AT for 60 min and then 30  m H2O2 for 40 min 
causes a drop to 2.7%. Thus, the inhibition of catalase enhances the toxic effect of H2O2. (Right) N2a cells stably transfected with tau have a 
lower initial number of long neurites (8.4%). They are diminished somewhat by 3-AT treatment (to 6.6%) but almost disappear after H2O2 
treatment (0.7%). In these conditions, a similar value (0.9%) is observed with 3-AT   H2O2 treatment because the peroxisomes are already 
excluded from the neurites (which is equivalent to catalase inhibition). Error bars show SEM; n   300. 
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2,5-diphenyltetrazolium bromide (MTT) test (which senses the
reducing capacity of mitochondria [Mattson et al., 1995]) or
the trypan blue test (which senses the leakiness of the plasma
membrane). By both assays, survival rates were the same in tau-
expressing and control cells (unpublished data). Furthermore,
we compared the metabolic pathways for the detoxification of
peroxides in N2a mock and tau-transfected cells. After treat-
ment of the cells with 100 
 
 
 
M H
 
2
 
O
 
2
 
, the concentration of the
peroxide decreased with comparable rates in both cell lines. The
inhibitory effect of 3-AT was also similar (
 
 
 
30%) and indicates
that catalase is mainly responsible for H
 
2
 
O
 
2
 
 detoxification in
both cell clones (unpublished data). Various concentrations (1
and 10 mM) of hydrogen peroxide were used to probe for an
involvement of the glutathione system in peroxide detoxifica-
tion. No immediate rise in glutathione disulfide was detectable
after the addition of the peroxide (Dringen et al., 1999); thus,
both cell clones make little use of glutathione peroxidase in
detoxification of peroxide. Therefore, we conclude that the ex-
pression of tau is not toxic by itself, it has no negative effect on
the overall biochemical pathways in the transfected cells as such,
so that the decrease in neurite growth and viability must be as-
cribed to the inhibition of transport processes.
 
The trafficking of APP is inhibited by tau
 
APP is a membrane protein implicated in Alzheimer’s disease
by improper proteolysis and accumulation of its A
 
 
 
 peptide
fragment. After synthesis in neurons, it is initially transported to
the axon by Golgi-derived vesicles, and later a small fraction
travels back to the dendrites by transcytosis (Simons et al.,
1995). Since tau inhibits the transport of vesicles down the
axon, we investigated whether tau would affect the anterograde
transport of APP as well using N2a cells stably transfected with
the human isoform APP
 
695
 
 (Thinakaran et al., 1996) and de-
Figure 4. Reduction of APP-containing vesicles in neurites of N2a 
cells by tau. (A) N2a cells stably overexpressing APP695 were 
differentiated for 1 d by serum deprivation and 1  M retinoic acid, 
and then transiently transfected with htau40 for 12 h. Cells were 
fixed by methanol and immunostained with antibodies against APP 
(myc tag) and tau (HA tag). (Left) Control cells without tau transfection 
show APP in the cell body and along neurites but no staining of tau. 
(Right) Cells transfected with tau show APP vesicles clustered in the 
Golgi area but not in the neurite (arrow), whereas tau is present 
throughout the neurite. (B) Quantitation: the number of APP vesicles 
stained with an antibody against human APP (B5 5313) in a stretch 
of 30- m length drops approximately threefold after expression of tau.
Figure 5. APP-YFP transport in cultured cortical neurons. (A) 
After 8 d in culture rat, cortical neurons were transfected with APP-YFP 
AV and analyzed 24 h later by live cell light microscopy. Confocal 
images were collected in 6-s time frames. The arrowheads and arrows 
point at two tubular vesicles carrying APP-YFP that move toward 
each other, crossover at t   48 s, and continue without interference 
(velocities: top particle, 0.60  m/s and bottom particle, 0.36  m/s). 
(B) Dual color live imaging of APP and tau in cultured cortical neurons 
cotransfected with APP-YFP and CFP-htau40 AV and analyzed 24 h 
later by live cell confocal microscopy. Transfected neuron expressing 
APP-YFP (top) and doubly transfected neuron expressing APP-YFP 
and CFP-htau40 (bottom). Note that APP alone distributes throughout 
the cell body and neurites (top), but with elevated tau it is largely
restricted to the cell body (bottom left), whereas tau is visible along 
the axons (bottom middle, arrow). 
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tecting it by immunofluorescence. The inhibition is indeed ob-
served. In the absence of tau, APP-containing vesicles can be vi-
sualized in the cell body around the Golgi area and throughout
the neurite (Fig. 4 A). When the cells are additionally trans-
fected with tau, it appears throughout the neurites (Fig. 4 A,
right), but APP vesicles are strongly reduced in the neurites after
12 h. Quantification shows that the level of APP-carrying vesi-
cles in neurites is decreased about threefold (Fig. 4 B) after tau
transfection comparable to the observations with Golgi-derived
vesicles in general (Fig. 1 B). The results demonstrate a direct
connection between the elevation of tau and the inhibition of
anterograde APP trafficking.
 
Time-lapse imaging of mitochondria, APP-derived, and 
Golgi-derived vesicles and effect of tau in cortical and 
retinal ganglion neurons
 
Thus far we have described the effect of tau on the distribution
of cell structures at fixed time points. The next step was to ob-
serve the movements of particles in real time in the presence or
absence of tau. To analyze the transport of fluorescent APP ves-
icles in living cultured cortical neurons in the presence and ab-
sence of overexpressed htau40, APP and htau40 were tagged
with yellow fluorescent protein (YFP) and cyan fluorescent pro-
tein (CFP), two spectral variants of green fluorescent protein
(GFP), which allow simultaneous detection of two different fu-
sion proteins in a living cell (Ellenberg et al., 1999; Lu and Ko-
sik, 2001). For transfection of the cultured hippocampal neu-
rons, the fusion constructs were each inserted into the genome
of an E1/E3-deleted replication-deficient AV (serotype Ad5).
Western Blots showed that the CFP-htau40 and APP-YFP pro-
teins were properly expressed (unpublished data). Anterograde
and retrograde movements of the YFP fluorescent structures
were observed in transfected hippocampal neurons. The exam-
ple of Fig. 5 A shows two particles moving toward each other at
mean velocities of 0.60 
 
 
 
m/s (anterograde) and 0.36 
 
 
 
m/s (ret-
rograde). Rapidly moving vesicles (instantaneous velocities up
to 10 
 
 
 
m/s) often had an elongated morphology, whereas
slowly or nonmoving fluorescent structures were globular. The
mobility of axonal particles was generally more pronounced in
the axons of cells with a low level of APP expression, whereas
higher APP concentrations tended to induce clusters of immo-
bile vesicles in “traffic jams.”
Although fluorescent particles were very visible in live cor-
tical neurons, their direction of movement was often ambig-
Figure 6. Time-lapse imaging of APP-YFP transport 
in cultured chick retinal ganglion neurons and 
inhibition by tau. (A) After 1 d in culture, the RGCs 
were transfected with APP-YFP AV and analyzed 48 h 
later (transfection rate 80%). Image frames were 
collected every 3.9 s. The arrowheads point at an 
elongated vesicle carrying APP-YFP moving rapidly 
toward the growth cone on the right (average velocity, 
4.5  m/s; instantaneous velocity, up to 7  m/s). The 
particle resides in the growth cone and eventually 
disappears. (B) Double transfection of RGCs with 
CFP-htau40 and APP-YFP (30% double transfection). 
The top shows the blue fluorescence of tau throughout 
the axon and growth cone, and the bottom shows yellow 
fluorescent APP vesicles. Very few particles are visible 
in the presence of tau, and they slowly move in the 
retrograde direction (0.4  m/s; arrowheads). (C) 
Quantification: fractions of particles moving in RGCs 
transfected with APP only or with APP and tau. Particle 
movement was classified by direction (anterograde 
and retrograde) and speed (bins of 1  m/s). Anterograde 
vesicles predominate, and speeds can be up to 7  m/s 
(clustered particles forming immobile traffic jams were 
not scored here). After transfection with tau, very few 
vesicles move, many are immobile (red bar), and slow 
speeds predominate in both directions.Tau blocks traffic in neurons | Stamer et al. 1057
uous, since the polarity of the cell processes and their iden-
tity (axon or dendrite) was not easily determined in the
absence of markers. Therefore, we turned to the model sys-
tem of chick RGCs where axons grow from a retinal explant
with a well-defined polarity on a laminin-coated surface and
show transport of APP vesicles (Walter et al., 1987; Morin
et al., 1993; Amaratunga and Fine, 1995). This system al-
lows the evaluation of parameters, such as anterograde and
retrograde direction of movement, the fraction of moving
particles, and the instantaneous and average velocities in
both directions. Fig. 6 A shows the tip and growth cone of
an axon of a retinal ganglion neuron after 50 h in culture, 24 h
after transfection with APP-YFP (efficiency 40–80%). The
highlighted elongated APP particle in Fig. 6 A moves with a
speed of 4.5  m/s toward the growth cone, remains station-
ary there, and eventually disappears. Instantaneous speeds of
this particle reaches up to 7  m/s. During the typical obser-
vation time of 6 min,  30% of the fluorescent vesicles were
moving; the rest of the vesicles were stationary and clustered
in immobile groups (these clusters were not included in the
analysis) (Fig. 6 C). Movement was recorded in 3.9-s time
intervals and occurred in both directions, predominantly
(80%) in the anterograde direction. Velocities were remark-
ably heterogeneous among different particles, and even a
given particle showed considerable variations in instanta-
neous speeds. 83 vesicles were scored in 13 axons in four ex-
periments (Fig. 6, A and C). The same analysis was applied
to cells labeled with fluorescent WGA (Fig. 7 A). In live
cells, lectins added to the medium are taken up by endocyto-
sis primarily in the neuronal cell body, accumulate in the
trans-Golgi network, and can then be found in vesicles de-
rived from the TGN (Gonatas and Avrameas, 1977). Thus,
the labeled structures observed after 15 h in the axon are
Golgi-derived vesicles. In this case, the fraction of moving
particles was smaller (20%) than with APP vesicles, and ve-
locities were slower (Fig. 7 C).
We next investigated the effect of tau on transport in
RGCs by cotransfecting CFP-htau40 and APP-YFP (effi-
ciency 20–40%). After 24 h, tau was expressed and distrib-
uted over the length of the axon and growth cone (Fig. 6 B,
top). At the bottom of Fig. 6 B, an APP particle is seen,
which slowly moves retrogradely with a speed of 0.4  m/s.
The overall effect on movement was dramatic: the axons be-
came essentially devoid of vesicles, and there were almost no
forward moving particles. The few remaining visible parti-
cles moved slowly ( 1  m/s) in the retrograde direction
and had a globular shape. A similar picture was seen with
WGA vesicle movements after transfection of RGCs with
Figure 7. Transport of Golgi-derived 
vesicles in chick retinal ganglion neurons. 
The growth cone is on the right (outside 
the picture frame). (A) After 2 d in culture, 
RGCs were stained with WGA, and 
movements of vesicles were monitored 
by confocal microscopy. The arrowheads 
point to an example of a retrogradely 
moving particle at 1.2  m/s. (B) After 2 d 
in culture, RGCs were transfected with 
CFP-tau, and 2 d later they were stained 
with WGA. The tau-expressing axon 
(top, blue) contains almost no 
WGA-stained vesicles; one of the rare 
retrograde movements is indicated by 
arrows (0.7  m/s; middle and bottom). 
By contrast, the axon not overexpressing 
tau (double arrows) contain numerous 
mobile particles. (C) Quantification of 
WGA vesicle transport without or with 
tau transfection. WGA particles generally 
move more slowly than APP vesicles. 
The distribution between slow and 
medium velocities (shown in 1  m/s 
bins) is roughly comparable without or 
with tau, but the absolute numbers of 
moving particles are much smaller after 
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CFP-htau40: very few particles were visible in the axon ex-
pressing tau (Fig. 7 B, top, blue and bottom, arrowhead),
and these were mostly stationary or moved only retrogradely
at slow or medium speeds (Fig. 7 B, middle and bottom, ar-
rowheads). By contrast, axons that do not express tau (Fig. 7
B, double arrows) have numerous vesicles, many of which
are mobile in both directions.
The same effect of overexpressed tau on the transport of
APP was seen in cultured hippocampal neurons, which were
simultaneously transfected with APP-YFP and CFP-htau40
by using the recombinant adenoviral vectors. A sufficient
amount of doubly transfected neurons was obtained ( 50%
of cells). Transfection of APP alone resulted in APP vesicles
distributed throughout the cell body and neurites (Fig. 5 B,
top left), but cells containing both transfected APP and tau
showed that APP was restricted mostly to the cell body, and
dendrites and axons were almost completely devoid of YFP
fluorescent vesicles (Fig. 5 B, bottom left). As a conse-
quence, only very few moving YFP fluorescent structures
could be observed, moving mainly retrogradely with veloci-
ties  0.4  m/s (in this case the axons were clearly defined
by the fluorescence of tau) (Fig. 5 B, arrow).
Similar experiments were performed to observe the move-
ment of mitochondria (stained with Mitotracker red) in
RGCs (Fig. 8). Without tau, most particles were mobile with
instantaneous velocities  1   m/s, and anterograde traffic
dominated (Fig. 8 A). After AV-mediated tau transfection,
about half of the mitochondria became immobile over ex-
tended periods, and the rest moved mainly retrogradely (Fig.
8 B). The quantification (Fig. 8 C) shows that tau biases the
particles toward the immobile and retrograde fractions with-
out significant changes in instantaneous velocities. These re-
sults explain the gradual disappearance of mitochondria from
the cell processes discussed above (Fig. 1 D).
Discussion
Tau expression in neurons and retrograde 
transport bias
Tau has a variety of functions, most prominently in microtu-
bule stabilization or neurite outgrowth (for reviews see Gun-
dersen and Cook, 1999; Garcia and Cleveland, 2001). An-
other emerging role is the effect of tau and related MAPs on
transport along microtubules (Sato-Harada et al., 1996; Bu-
Figure 8. Transport of mitochondria in chick retinal 
ganglion neurons. The growth cone is on the right 
(outside the picture frame). (A) After 2 d in culture, 
RGCs were stained with MitoTracker green, and 
movements of mitochondria were monitored by 
confocal microscopy. The triangular arrowhead 
(middle) points at a nearly immobile particle (with 
only small excursion in either direction). The slender 
arrowhead (right) and the open arrowhead show 
particles with anterograde movement. Average 
velocities are  0.5  m/s, but instantaneous velocities 
are  1  m/s. (B) After 2 d in culture, RGCs were 
transfected with CFP-tau by AV (5 h) and incubated 
overnight with MitoTracker red and observed 24 h 
later by confocal microscopy. The tau-expressing 
axon (top, blue) contains very few mitochondria, 
which are mostly stationary or gradually move 
retrogradely (arrowheads). By contrast, the axons not 
overexpressing tau contain numerous mobile particles. 
(C) Quantification of mitochondria transport in 1  m/s 
bins without or with tau transfection (left and right). 
Instantaneous velocities are similar in both direction 
(mostly  1  m/s). Without tau, 20% of the
mitochondria are immobile, 55% move anterogradely, 
and 25% move retrogradely. With tau, this distribution 
shifts to  50% immobile,  50% retrograde, and only 
a small fraction shows anterograde movement.Tau blocks traffic in neurons | Stamer et al. 1059
linski et al., 1997; Ebneth et al., 1998). This emphasizes the
interplay between the cytoskeletal fibers and motors in inte-
grating the physiological functions within cell processes
(Bradke and Dotti, 1998; Rogers and Gelfand, 2000). Tau
influences the rates of attachment and detachment of motors
from microtubules with the net result that dynein-mediated
movements (toward the cell center) become predominant
(Trinczek et al., 1999). The effect is strictly dependent on
the binding of tau to microtubules; as shown previously,
variants of tau which lack the microtubule-binding domain
do not have an effect on transport, and conversely the size
and composition of the nonbinding domains is of little im-
portance (Ebneth et al., 1998; Trinczek et al., 1999). Simi-
larly, other proteins have an effect on transport as long as
they bind tightly to microtubules, such as MAP4 (Bulinski et
al., 1997) or MAP2 (unpublished data). The predominance
of minus-directed transport leads to the retraction of slow
moving cell components, such as the ER, mitochondria, or
peroxisomes. The transport bias can be overcome by inhibit-
ing the retrograde motor dynein or by diffusion, that is, our
earlier results on CHO cells showed that small vesicles with
high mobility could still distribute throughout the cytoplasm
even though their run lengths became shorter. Given this
background, we asked what the effect of tau would be on
highly asymmetric cells such as neurons where diffusion is
much more restricted. Tau is the predominant MAP in ax-
ons (Binder et al., 1985; Riederer and Binder, 1994); if the
plus-end–directed transport were retarded by elevated tau,
this would impair the supply of material and energy to the
growth cone and make the cell processes vulnerable. This is-
sue gains additional significance in the context of Alzhei-
mer’s disease and related tauopathies, which are characterized
by the elevation and aggregation of tau (see below).
We have tested three types of cells: differentiated neuro-
blastoma cells, primary hippocampal neurons from rat or
mouse brain, and chick RGCs. Tau was elevated either by
stable or transient transfection, transfection with viral vec-
tors (AV or HSV), or the calcium phosphate method. We
studied the distribution of cytoskeletal components (micro-
tubules, tau, and neurofilaments), organelles (mitochondria
and peroxisomes), and vesicles derived from the Golgi com-
plex, in particular vesicles carrying APP. In addition, we
monitored the growth of neurites and their response to oxi-
dative stress. All of the observed effects support the view that
tau generally inhibits transport along microtubules, prefer-
entially in the plus-end direction, that is, toward the growth
cone. This applies to organelles, vesicles, and neurofilaments
(Figs. 1–3). The inhibition of transport is so efficient that
organelles are largely excluded from cell processes, and vesi-
cles are dramatically reduced (Fig. 1 C). In this regard, neu-
rons are more vulnerable than the CHO cells studied earlier
because diffusion is too limited. The effects of tau are ob-
served both in neuron-like cell models (N2a), primary neu-
rons, and RGCs, confirming that the underlying interac-
tions between microtubules, motors, and cargo are similar.
The inhibition of organelles, vesicles, and neurofilaments
is consistent with the view that these components are car-
ried down the axon by a kinesin-dependent transport along
microtubules (Hirokawa et al., 1998; Baas, 1999; Chou et
al., 2001; Goldstein, 2001; Shea and Flanagan, 2001; Zhou
et al., 2001). The motor-cargo connection may be direct
(Liao and Gundersen, 1998; Yabe et al., 1999; Kamal et al.,
2000), or it could be mediated by adaptor proteins (Morris
and Hollenbeck, 1995; Ratner et al., 1998; Setou et al.,
2000; Verhey et al., 2001). By contrast, the inhibition does
not apply to microtubules or their associated proteins (e.g.,
tau itself), presumably because their transport into the cell
process is mediated by a different type of mechanism. This
would be consistent with the assumption that microtubules
and MAPs might be carried by a dynein-mediated transport
along actin microfilaments (Sheetz et al., 1998; Baas,
1999). Thus, tau highlights the difference between micro-
tubules and neurofilaments even though both are trans-
ported as “slow components” of axonal transport. Using
GFP-tagged intermediate filament subunits, several groups
showed recently that they are transported by a fast motor of
the kinesin family except that the average speed in axons is
slowed down by frequent long pauses (Roy et al., 2000;
Wang et al., 2000).
It is interesting to compare the tau-induced transport ef-
fects with the accumulation of proteins into aggresomes
(Kopito, 2000). There is a superficial similarity because in
both cases there is a net transport toward the microtubule
minus ends around the MTOC. Aggresomes are formed by
improperly folded and aggregated proteins, which are trans-
ported toward the cell center by a dynein-mediated process.
They selectively contain cellular factors engaged in protein
folding or degradation, such as proteasomes, heat shock pro-
teins, and enzymes of the ubiquitin pathway, but aggresome
formation does not affect the distribution of organelles such
as mitochondria, peroxisomes, or the ER. Moreover, ag-
gresomes represent the cell’s response to (nearly) irrevers-
ible protein aggregation (e.g., proteins with polyglutamine
stretches [Muchowski et al., 2000]); this does not occur with
tau protein in transfected cells, which remains either micro-
tubule-bound or highly soluble in the cytosol (Preuss et al.,
1997; Lu and Kosik 2001). Finally, aggresomes cannot be
redispersed, in contrast to the clusters of cell components
described here, which dissolve again when microtubules are
destroyed or when dynein-mediated transport is impaired
(e.g., by dynamitin expression [Ebneth et al., 1998]).
One can expect that transport inhibition has serious con-
sequences for the growth and survival of cell processes. We
have tested this for two cases, the growth of neurites and
their vulnerability to oxidative stress. Indeed, tau-transfected
cells have shorter neurites (Fig. 3 A, bottom), and they be-
come highly sensitive to oxidative conditions (H2O2). This
is due to the absence of peroxisomes, since exogenous cata-
lase can provide substantial protection (Fig. 3 B, left). The
alternative pathway of detoxification by glutathione peroxi-
dase plays little role in neurons (Dringen et al., 1999), and
we have verified this for our cell lines (unpublished data).
The role of catalase can be probed specifically with the cata-
lase inhibitor 3-AT. In control cells, it amplifies the toxic ef-
fect of H2O2 but not in tau-expressing cells (Fig. 3 C). Thus,
roughly speaking the loss of peroxisomes from the neurites
due to elevated tau is as damaging as the direct inhibition of
catalase. By the same argument, the exclusion of mitochon-
dria from the cell processes implies a local depletion of ATP.
This might be bearable for a compact cell where ATP dif-1060 The Journal of Cell Biology | Volume 156, Number 6, 2002
fuses throughout the cytoplasm but becomes a problem in
extended cell processes.
Implications of tau-induced transport defects for 
neurodegeneration
The results described here may be important for under-
standing neurodegenerative disorders such as Alzheimer’s
disease, frontotemporal dementias, and others, which are
characterized by elevated and aggregated tau protein (for re-
views see Buee et al., 2000; Hutton, 2001). Alzheimer’s dis-
ease is traditionally characterized by two types of protein
deposits in the brain, the extracellular amyloid plaques, con-
sisting largely of the peptide A , a derivative of the mem-
brane protein APP, and the intracellular neurofibrillary tan-
gles, consisting mostly of tau protein (Price et al., 1998).
However, these visible signs of pathology must be preceded
by more subtle changes. The progression of the disease cor-
relates with the spreading of the neurofibrillary tangles,
whereas the amyloid plaques have a more generalized distri-
bution (Braak and Braak, 1991; Arriagada et al., 1992). One
of the earliest detectable signs is the loss of synapses and ret-
rograde degeneration (“dying back”) of neurons, which ap-
pears to be accompanied by a decay of intracellular transport
(Terry, 1998). We suggest that the data presented here speak
both to the amyloid and the tau dysfunction, linking them
through the impairment of intracellular traffic.
APP appears to have neurotrophic functions and is carried
by kinesin-driven vesicles along axons and dendrites (Fer-
reira et al., 1993; Amaratunga et al., 1995; Simons et al.,
1995; Kaether et al., 2000). The anterograde movement is
dependent on a kinesin motor; specifically, the cytosolic
COOH-terminal tail of APP interacts directly with a kinesin
light chain (Kamal et al., 2000). Despite their high mobility,
the APP vesicles are effectively eliminated from the axon
once tau becomes elevated, and APP is found concentrated
in the cell body (Fig. 5 B, bottom). This is a prominent lo-
cus for the generation of the A  peptides; in particular, both
A 40 and the more toxic variant A 42 are generated in the
trans-Golgi network (Xu et al., 1997). Thus, if the dwell
time of APP were increased by a tau-dependent retardation
of traffic one would expect an increase in the production of
A  with the known pathological consequences of aggrega-
tion and toxicity. This would be analogous to the increased
accumulation of A  by other treatments, which inhibit vesi-
cle budding or transport (Greenfield et al., 1999). We note
that the inhibition of APP transport by tau is a robust phe-
nomenon that can be achieved in different cell models, for
example, by transient transfection of tau in N2a cells stably
transfected with APP or transfecting primary cortical or reti-
nal ganglion neurons with APP and tau using AV vectors. In
the latter case, the transfected proteins were tagged with flu-
orescent markers (YFP for APP and CFP for tau), which al-
lows one to monitor vesicle movements and tau distribu-
tions by two-color live cell imaging. Several features were
notable. (a) APP vesicles can be remarkably fast: whereas the
known kinesins typically move  0.6–0.8   m/s in vitro,
APP vesicles in cortical and RGCs can reach up to 10  m/s.
(b) Fast transport occurs mainly in the anterograde direc-
tion: retrograde movement is generally slower, correspond-
ing to the activity of dynein (Fig. 6 C). These results are in
good agreement with recent findings by Kaether et al.
(2000). (c) The majority of mobile particles (80%) moves
anterogradely. This is the main reason for the strong bias of
transport toward the synapse, independently of other trans-
port characteristics. (d) Transport is nearly halted in both di-
rections when tau is increased, that is, the number of mov-
ing particles becomes minute and the few mobile ones are
retrograde (Fig. 6, B and C). (e) Remarkably, the transport
infrastructure is much more resistant than traffic itself: mi-
crotubule tracks survive for many hours after mitochondria,
peroxisomes, neurofilaments, APP vesicles, and others have
deserted the neurite and accumulated in the cell body (Fig.
3), but eventually microtubules also disappear when the cell
processes degenerate. On the basis of these data, one could
imagine two potential causes for neuronal damage due to
transport inhibition of APP. One is the depletion of APP
from the synapse where it would loose its neurotrophic func-
tion (loss of function), and the second is its retention in the
cell body where increased levels of A  would be produced
(gain of toxic function). It remains to be seen which of these
is more important in the context of brain tissue.
With regard to tau protein, the most visible change in Alz-
heimer’s disease and related tauopathies is the aggregation
into neurofibrillary tangles, which is accompanied by an in-
crease in the level of tau, hyperphosphorylation, and loss of
microtubule binding in the affected neurons. These observa-
tions are usually interpreted within a hypothesis where the
physiological function of tau (stabilization of microtubules)
is disrupted due to excess phosphorylation; the unbound tau
then is thought to aggregate in a pathological manner and
obstructs the cell interior, and the microtubules disassemble
so that axonal transport is disrupted (for review see Buee et
al., 2000). This hypothesis is based on the view that tau’s
role is to promote neurite outgrowth by stabilizing microtu-
bule bundles. Indeed, tau is upregulated during neuronal
differentiation, adult isoforms are generated by alternative
splicing, and phosphorylation then gradually decreases, all of
which favor tighter binding of tau to microtubules (Mandell
and Banker, 1996). Thus, the presence of tau would appear
to be beneficial for the neuron. However, several observa-
tions do not fit into this scheme: tau-deficient transgenic
mice show no major phenotype, since tau can be substituted
by other cofactors (MAP1b) (Takei et al., 2000), mice over-
expressing tau show transport defects even though microtu-
bules are intact and tau aggregates are absent or minor (Ishi-
hara et al., 1999; Götz et al., 2001; Lewis et al., 2001), and
tau-overexpressing flies also show defects in neuronal traffic
without evidence of tau aggregation (Wittmann et al.,
2001). These observations argue that even “normal” tau may
be detrimental when it becomes elevated.
How can we reconcile the requirement for tau in neurite
outgrowth with the damage inflicted on transport? A hint
comes from the fact that the tau to tubulin ratio is normally
quite low, in the range of a few percent (Cleveland et al.,
1977). This means that relatively few tau molecules may suf-
fice to initiate a growing neurite, and the tau concentration
required for microtubule stabilization along the axon may be
low in the presence of other stabilizing factors (consistent
with the tau knockout results [Harada et al., 1994]). Thus,
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negligible. However, it can become noticeable if tau be-
comes elevated in degenerating neurons as reported by
Khatoon et al. (1992). The reason for the increase in tau is
unclear, but one possibility is the neuron’s tendency for re-
active sprouting to counteract toxic challenges in an aging
brain (Savaskan and Nitsch, 2001). Once traffic jams are
initiated, they are exacerbated by the loss of mitochondria
and peroxisomes from the axons, eventually speeding up de-
generation. This could be the situation mimicked by the cell
models described here. In conclusion, tau may be beneficial
for the neuron at physiologically low concentrations but be-
comes detrimental if the concentration is elevated. This may
simply happen in response to an adverse cellular environ-
ment or a consequence of a possible transcription factor ac-
tivity of the cleaved COOH-terminal stub of APP (as pro-
posed recently [Cao and Sudhof, 2001]). In addition, the
cell could make use of the “friction” of tau to actively regu-
late intracellular transport. This could be achieved by regu-
lating the concentration of tau or more flexibly by the ki-
nases and phosphatases that determine tau’s affinity for
microtubules. Thus, pathological “hyperphosphorylation”
could be the neuron’s response to a traffic jam.
Materials and methods
Cell lines
N2a neuroblastoma cells were grown in MEM with Earle’s salts supple-
mented with 10% FCS, 1 mM glutamine, and 1% nonessential amino acids
(Sigma-Aldrich) at 37 C with 5% CO2. Differentiation was induced by 1
 M retinoic acid, 0.1% FCS at a density of 2   10
4 cells per cm
2 for 24–48 h.
N2a cells were stably transfected with tau as described (Ebneth et al.,
1998). An N2a neuroblastoma cell line stably transfected with APP695
was provided by Drs. G. Thinakaran and S. Sisodia (University of Chicago,
Chicago, IL) (Thinakaran et al., 1996). Wistar rats and C57black mice for
the preparation of primary neurons were obtained from the animal facility
of Hamburg University Medical School.
Fusion proteins
APP-EYFP. EYFP cDNA (CLONTECH Laboratories, Inc.) without start codon
was fused to the 3  end of human APP695 cDNA omitting the stop codon.
The COOH-terminal part of APP was amplified from pSG5-hAPP695 (pro-
vided by B. De Strooper, Katholieke Universiteit Leuven, Leuven, Bel-
gium). The fragment with HA tag was subcloned into a pCR Blunt II TOPO
vector using the Zero Blunt TOPO cloning kit (Invitrogen). The resulting
plasmid pCR Blunt II APP-HA was used for the insertion of EYFP DNA. The
obtained fragment was subcloned into pCR Blunt II TOPO vector. The
EYFP fragment was purified and cloned into pCR Blunt II APP-HA vector to
obtain pCR Blunt II APP-HA-EYFP. The sequences generated by PCR were
checked by sequencing.
ECFP-htau40. The plasmid pECFP-htau40 was provided by J. Kupper,
Max-Plank-Institute for Biochemistry, Martinsried, Germany. To allow the
cloning of ECFP-htau40 into an AV vector, the SalI restriction site was in-
troduced at the 5  end of the ECFP-htau40 cDNA using QuikChange site-
directed mutagenesis (Stratagene).
AV vectors encoding fluorescent fusion proteins
Recombinant AVs were generated following He et al. (1998). Briefly, the
SalI-XbaI fragment that contained the CFP-htau40 cDNA and the HindIII-
XbaI fragment that contained the APP-YFP cDNA were subcloned into the
respective restriction sites of the pShuttle-CMV vector. The resulting plas-
mids were linearized with PmeI and cotransfected with the pAdEasy 1 vec-
tor into Escherichia coli BJ 5183 for homologous recombination. Plasmid
DNA was amplified in E. coli DH10B and digested with PacI to cut out the
entire recombinant adenoviral DNA, which was transfected into 911 cells,
using Lipofectamine transfection (Life Technologies). The generation of the
viruses in the 911 cells was monitored by fluorescence microscopy using
an Axioplan fluorescence microscope (ZEISS). The cells were harvested,
resuspended in PBS, and lysed by three freeze-thaw cycles. Cellular debris
and nuclei were removed by centrifugation, and the virus suspension was
purified by two CsCl gradient centrifugations. CsCl was removed by gel fil-
tration and equilibrated in storage buffer (10 mM Tris/Cl, 135 mM NaCl, 3
mM KCl, 1 mM MgCl2, 10% glycerol, pH 8.0).
Transfection of primary cortex and retinal ganglion neurons
Cultures of E18 (rat) or E15 (mouse) hippocampal neurons were prepared
according to Banker and Goslin (1998). Cells were plated in HBSS buffer
(Biochrom) at a density of 7   10
4 cells per cm
2 on a glass surface coated
with poly-L-lysine (0.01% in 100 mM borate buffer, pH 8.5) and fibronec-
tin (0.001% in HBSS; Life Technologies). To cultivate the neurons for live
observation, 4.3 cm
2 Lab-Tek chambers were used (Nunc) and coated as
described above. Cells were transfected with tau either using a HSV vector
or an AV vector. Cells were transfected between days 4 and 8 in culture.
The HSV virus carrying the gene of htau40 was provided by Dr. R. Brandt,
University of Heidelberg, Heidelberg, Germany. 10  l virus suspension
was added per 1.5   10
5 cells and incubated for 48 h. Then, the cells were
fixed for immunofluorescence. For adenoviral transfection of APP-YFP or
CFP-htau40, a 100-fold multiplicity of infection (multiplicity of infection of
100, 3   10
7 infectious particles) was applied to primary neurons. In the
case of double transfections, 3   10
7 infectious particles of each recombi-
nant AV were added. After 4 h incubation, the viral suspensions were re-
moved. Vesicle movement was observed by confocal microscopy 24–48 h
after transfection.
RGCs were prepared from white leghorn chicken eyes at embryonic day
7. Glass bottom dishes were coated overnight with 4  g/ml laminin
(Sigma-Aldrich), washed with sterile H2O, and dried. Retinae were
mounted on nitrocellulose filter as described previously (Walter et al.,
1987) and cut with a scalpel into 1–2-mm-wide stripes. Retinal explant
was placed into the dish, and DME-F12 media (GIBCO BRL) with 10%
FCS and 0.4% methyl cellulose was added. Explants were then cultured for
24 h at 37 C, 5% CO2 and 100% relative humidity prior viral transfection.
Transfection and observation was done as above.
For staining of mitochondria in RGCs, the medium was removed 24–48 h
after explantation of the retina and replaced with medium containing Mi-
toTracker red 589 (Molecular Probes) at a final concentration of 12 nM or
MitoTracker green FM (Molecular Probes) at a final concentration of 100
nM. Cells were incubated overnight under growth conditions. Then, the
MitoTracker solution was replaced with fresh prewarmed medium, and
movement of mitochondria was observed. For double labeling with CFP-
tau AV, virus was added and removed after 5 h of incubation. MitoTracker
red solution was added overnight. The expression of tau and the move-
ment of mitochondria were observed by confocal microscopy 24–48 h af-
ter transfection.
Antibodies and dyes
Rat monoclonal antitubulin antibody YL1/2 and mouse monoclonal anti-
body DM1A were purchased from Serotec and Sigma-Aldrich. Polyclonal
rabbit antitau antibody K9JA was from Dako, polyclonal rabbit anti-PMP69
antibody for peroxisomes was a gift from Dr. W. Just (University of Heidel-
berg, Heidelberg, Germany). All fluorescently (TRITC, FITC, and AMCA)
labeled secondary antibodies were from DIANOVA. Fluorescent dyes Mi-
toTracker red and rhodamine-labeled WGA were purchased from Molecu-
lar Probes. The monoclonal mouse antibody SMI32 (Chemicon) was used
for the detection of unphosphorylated neurofilaments. The monoclonal tag
antibodies from mouse against HA tag (12CA5) and myc tag were obtained
from Roche Diagnostics and Invitrogen. Polyclonal antibody B5 (5313)
against human APP (residues 444–592) was a gift from Dr. C. Haass (Uni-
versity of München, München, Germany), and monoclonal antibody 6E10
was from Senetek.
Immunofluorescence
Neurons and neuroblastoma cells were fixed in methanol or 2% parafor-
maldehyde and incubated with antibodies. Cells were examined with an
Axioplan fluorescence microscope (ZEISS) equipped with an 100  oil-
immersion objective and filters optimized for triple label experiments
(FITC, TRITC, and AMCA fluorescence). Pictures were taken with a cooled
CCD camera (Visitron) and analyzed using the MetaMorph software package.
Quantification of vesicles, organelles, and neurofilament protein 
in N2a cells
Peroxisomes were stained with polyclonal anti-PMP69 antibody (45 min,
1:200). Golgi-derived vesicles were stained with 10  M rhodamine-
labeled WGA (Molecular Probes) for 5 min after methanol fixation. Mito-
chondria were visualized by adding 400 nM MitoTracker red (Molecular
Probes) for 30 min in media at 37 C before fixation. Vesicles carrying APP
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or polyclonal anti-APP antibody (1:300). After fixation and immunofluo-
rescence labeling, the pictures were recorded and a defined area (20–30
 m in length for N2a cells and 50  m for neurons) beginning at the proxi-
mal neurite was circumscribed manually with the MetaMorph drawing
tools. Usually  100 cells were recorded per experiment. Afterwards, sig-
nals of vesicles and organelles above the background threshold were visu-
alized and counted using the threshold function of MetaMorph. Both in
tau- and mock-transfected cells we quantified and compared commensu-
rate areas.
Live cell light microscopy
For visualizing tau, primary cortex neurons (E18) were transfected at day 4
in culture with CFP-tau40 AV (or control virus) at multiplicity of infection
of 30 for 24 h. For tracking APP vesicles, transfection with APP-YFP AV at
multiplicity of infection of 100 was done at day 8 in culture for 4 h, and
analysis was done 24 h later. For observing vesicles labeled with fluores-
cent lectins, cells at day 4 in culture were incubated with rhodamine-
WGA (Molecular Probes) at a final concentration of 4  g/ml for 15 min.
Vesicles were tracked with an Axioplan fluorescence microscope (ZEISS).
To visualize CFP fluorescence of CFP-htau40, the FITC filter set was em-
ployed; WGA-rhodamine–labeled vesicles were observed by using the
TRITC filter set. The object plane was kept at 37 C by air heating. APP-YFP
vesicles were tracked with a LSM 510 confocal microscope (ZEISS),
equipped with an 63  oil-immersion objective, beam path, and laser set-
tings for YFP and CFP fluorescence and a 37 C air-heated object plane. Im-
age analysis was performed with LSM 510 software.
Response of cells to oxidative stress
N2a cells differentiated on coverslips were incubated in 150  M H2O2 in
MEM medium for 40 min or more. Cells were fixed in methanol, stained
for immunofluorescence with antibodies K9JA (for tau) and YL1/2 (for tu-
bulin), and the number and length of neurites was recorded. Protection
against H2O2 was done by adding catalase (0.02 U/ l; Sigma-Aldrich) im-
mediately after H2O2. Catalase was inhibited by 3-AT (Sigma-Aldrich) in
concentrations of 0.1, 1, and 10 mM and incubating for 30 or 60 min be-
fore the addition of H2O2. The integrity of mitochondria was measured by
the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide test, and
the viability of cells was measured by the trypan blue assay (Mattson et al.,
1995). The capacity of the glutathione system for peroxide detoxification
was determined following Dringen et al. (1999).
We thank G. Thinakaran and S. Sisodia (University of Chicago) for APP-
expressing N2a cells, R. Brandt (University of Heidelberg) for the HSV vec-
tor containing htau40, and B. De Strooper (Katholieke Universiteit Leuven)
for the APP plasmid. Antibodies against peroxisomes were kindly provided
by W. Just (University of Heidelberg). We are grateful to J. Biernat, A. Marx
(Hamburg) and T. Shea (University of Massachusetts, Lowell, Massachu-
setts) for help with clones, data processing, and stimulating discussions,
and to K. Neumann and N. Habbe for excellent technical assistance.
This research was supported in part by the Deutsche Forschungsge-
meinschaft.
Submitted: 13 August 2001
Revised: 21 January 2002
Accepted: 1 February 2002
References
Amaratunga, A., and R.E. Fine. 1995. Generation of amyloidogenic C-terminal
fragments during rapid axonal transport in vivo of beta-amyloid precursor
protein in the optic nerve. J. Biol. Chem. 270:17268–17272.
Amaratunga, A., S.E. Leeman, K.S. Kosik, and R.E. Fine. 1995. Inhibition of kine-
sin synthesis in vivo inhibits the rapid transport of representative proteins for
three transport vesicle classes into the axon. J. Neurochem. 64:2374–2376.
Arriagada, P.V., J.H. Growdon, E.T. Hedley-Whyte, and B.T. Hyman. 1992.
Neurofibrillary tangles but not senile plaques parallel duration and severity
of Alzheimer’s disease. Neurology. 42:631–639.
Baas, P.W. 1999. Microtubules and neuronal polarity: lessons from mitosis. Neu-
ron. 22:23–31.
Banker, G.A., and K. Goslin. 1998. Culturing Nerve Cells. MIT Press, Cam-
bridge, Massachusetts. 666 pp.
Binder, L.I., A. Frankfurter, and L.I. Rebhun. 1985. The distribution of tau in the
mammalian central nervous system. J. Cell Biol. 101:1371–1378.
Braak, H., and E. Braak. 1991. Neuropathological staging of Alzheimer-related
changes. Acta Neuropathol. 82:239–259.
Bradke, F., and C.G. Dotti. 1998. Membrane traffic in polarized neurons. Bio-
chim. Biophys. Acta. 1404:245–258.
Brandt, R., J. Leger, and G. Lee. 1995. Interaction of tau with the neural plasma
membrane mediated by tau’s amino-terminal projection domain. J. Cell
Biol. 131:1327–1340.
Buee, L., T. Bussiere, V. Buee-Scherrer, A. Delacourte, and P.R. Hof. 2000. Tau
protein isoforms, phosphorylation and role in neurodegenerative disorders.
Brain Res. Brain Res. Rev. 33:95–130.
Bulinski, J.C., T.E. McGraw, D. Gruber, H.L. Nguyen, and M.P. Sheetz. 1997.
Overexpression of MAP4 inhibits organelle motility and trafficking in vivo.
J. Cell Sci. 110:3055–3064.
Caceres, A., and K.S. Kosik. 1990. Inhibition of neurite polarity by tau antisense
oligonucleotides in primary cerebellar neurons. Nature. 343:461–463.
Cao, X., and T.C. Sudhof. 2001. A transcriptionally active complex of APP with
Fe65 and histone acetyltransferase Tip60. Science. 293:115–120.
Chou, Y.H., B.T. Helfand, and R.D. Goldman. 2001. New horizons in cytoskele-
tal dynamics: transport of intermediate filaments along microtubule tracks.
Curr. Opin. Cell Biol. 13:106–109.
Cleveland, D.W., S.Y. Hwo, and M.W. Kirschner. 1977. Physical and chemical
properties of purified tau factor and the role of tau in microtubule assembly.
J. Mol. Biol. 116:227–247.
Dringen, R., L. Kussmaul, J.M. Gutterer, J. Hirrlinger, and B. Hamprecht. 1999.
The glutathione system of peroxide detoxification is less efficient in neurons
than in astroglial cells. J. Neurochem. 72:2523–2530.
Drubin, D.G., and M.W. Kirschner. 1986. Tau protein function in living cells. J.
Cell Biol. 103:2739–2746.
Ebneth, A., R. Godemann, K. Stamer, S. Illenberger, B. Trinczek, and E. Man-
delkow. 1998. Overexpression of tau protein inhibits kinesin-dependent
trafficking of vesicles, mitochondria, and endoplasmic reticulum: implica-
tions for Alzheimer’s disease. J. Cell Biol. 143:777–794.
Ellenberg, J., J. Lippincott-Schwartz, and J.F. Presley. 1999. Dual-colour imaging
with GFP variants. Trends Cell Biol. 9:52–56.
Ferreira, A., A. Caceres, and K.S. Kosik. 1993. Intraneuronal compartments of the
amyloid precursor protein. J. Neurosci. 13:3112–3123.
Garcia, M.L., and D.W. Cleveland. 2001. Going new places using an old MAP:
tau, microtubules and human neurodegenerative disease. Curr. Opin. Cell
Biol. 13:41–48.
Goldstein, L.S. 2001. Kinesin molecular motors: transport pathways, receptors,
and human disease. Proc. Natl. Acad. Sci. USA. 98:6999–7003.
Gonatas, N.K., and S. Avrameas. 1977. Detection of carbohydrates with lectin-per-
oxidase conjugates. Methods Cell Biol. 15:387–406.
Götz, J., F. Chen, J. van Dorpe, and R.M. Nitsch. 2001. Formation of neurofibril-
lary tangles in P301L tau transgenic mice induced by AB42 fibrils. Science.
293:1491–1495.
Greenfield, J.P., J. Tsai, G.K. Gouras, B. Hai, G. Thinakaran, F. Checler, S.S. Si-
sodia, P. Greengard, and H. Xu. 1999. Endoplasmic reticulum and trans-
Golgi network generate distinct populations of Alzheimer beta-amyloid pep-
tides. Proc. Natl. Acad. Sci. USA. 96:742–747.
Gundersen, G.G., and T.A. Cook. 1999. Microtubules and signal transduction.
Curr. Opin. Cell Biol. 11:81–94.
Harada, A., K. Oguchi, S. Okabe, J. Kuno, S. Terada, T. Ohshima, R. Sato-Yoshi-
take, Y. Takei, T. Noda, and N. Hirokawa. 1994. Altered microtubule orga-
nization in small-calibre axons of mice lacking tau protein. Nature. 369:
488–491.
He, T.C., S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein. 1998. A
simplified system for generating recombinant adenoviruses. Proc. Natl. Acad.
Sci. USA. 95:2509–2514.
Hirokawa, N., Y. Noda, and Y. Okada. 1998. Kinesin and dynein superfamily pro-
teins in organelle transport and cell division. Curr. Opin. Cell Biol. 10:60–
73.
Hutton, M. 2001. Missense and splice site mutations in tau associated with FTDP-
17: multiple pathogenic mechanisms. Neurology. 56:S21–S25.
Ishihara, T., M. Hong, B. Zhang, Y. Nakagawa, M.K. Lee, J.Q. Trojanowski, and
V.M. Lee. 1999. Age-dependent emergence and progression of a tauopathy
in transgenic mice overexpressing the shortest human tau isoform. Neuron.
24:751–762.
Ishihara, T., M. Higuchi, B. Zhang, Y. Yoshiyama, M. Hong, J.Q. Trojanowski,
and V.M. Lee. 2001. Attenuated neurodegenerative disease phenotype in tau
transgenic mouse lacking neurofilaments. J. Neurosci. 21:6026–6035.
Kaether, C., P. Skehel, and C.G. Dotti. 2000. Axonal membrane proteins areTau blocks traffic in neurons | Stamer et al. 1063
transported in distinct carriers: a two-color video microscopy study in cul-
tured hippocampal neurons. Mol. Biol. Cell. 11:1213–1224.
Kamal, A., G.B. Stokin, Z. Yang, C.H. Xia, and L.S. Goldstein. 2000. Axonal
transport of amyloid precursor protein is mediated by direct binding to the
kinesin light chain subunit of kinesin-I. Neuron. 28:449–459.
Khatoon, S., I. Grundke-Iqbal, and K. Iqbal. 1992. Brain levels of microtubule-
associated protein tau are elevated in Alzheimer’s disease: a radioimmuno-
slot-blot assay for nanograms of the protein. J. Neurochem. 59:750–753.
Kopito, R.R. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends
Cell Biol. 10:524–530.
Lee, G., S.T. Newman, D.L. Gard, H. Band, and G. Panchamoorthy. 1998. Tau
interacts with src-family non-receptor tyrosine kinases. J. Cell Sci. 111:
3167–3177.
Lewis, J., D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen,
N. Sahara, L. Skipper, D. Yager, et al. 2001. Enhanced neurofibrillary de-
generation in transgenic mice expressing mutant tau and APP. Science. 293:
1487–1491.
Liao, G., and G.G. Gundersen. 1998. Kinesin is a candidate for cross-bridging mi-
crotubules and intermediate filaments. Selective binding of kinesin to dety-
rosinated tubulin and vimentin. J. Biol. Chem. 273:9797–9803.
Liao, H., Y. Li, D.L. Brautigan, and G.G. Gundersen. 1998. Protein phosphatase 1
is targeted to microtubules by the microtubule-associated protein Tau. J.
Biol. Chem. 273:21901–21908.
Lu, M., and K.S. Kosik. 2001. Competition for microtubule-binding with dual ex-
pression of tau missense and splice isoforms. Mol. Biol. Cell. 12:171–184.
Mandell, J.W., and G.A. Banker. 1996. A spatial gradient of tau protein phos-
phorylation in nascent axons. J. Neurosci. 16:5727–5740.
Mattson, M.P., S.W. Barger, J.G. Begley, and R.J. Mark. 1995. Calcium, free rad-
icals, and excitotoxic neuronal death in primary cell culture. Methods Cell
Biol. 46:187–216.
Morin, P.J., C.R. Abraham, A. Amaratunga, R.J. Johnson, G. Huber, J.H. Sandell,
and R.E. Fine. 1993. Amyloid precursor protein is synthesized by retinal
ganglion cells, rapidly transported to the optic nerve plasma membrane and
nerve terminals, and metabolized. J. Neurochem. 61:464–473.
Morris, R.L., and P.J. Hollenbeck. 1995. Axonal transport of mitochondria along
microtubules and F-actin in living vertebrate neurons. J. Cell Biol. 131:
1315–1326.
Muchowski, P.J., G. Schaffar, A. Sittler, E.E. Wanker, M.K. Hayer-Hartl, and
F.U. Hartl. 2000. Hsp70 and hsp40 chaperones can inhibit self-assembly of
polyglutamine proteins into amyloid-like fibrils. Proc. Natl. Acad. Sci. USA.
97:7841–7846.
Preuss, U., J. Biernat, E.M. Mandelkow, and E. Mandelkow. 1997. The ‘jaws’
model of tau-microtubule interaction examined in CHO cells. J. Cell Sci.
110:789–800.
Price, D.L., S.S. Sisodia, and D.R. Borchelt. 1998. Genetic neurodegenerative dis-
eases: the human illness and transgenic models. Science. 282:1079–1083.
Ratner, N., G.S. Bloom, and S.T. Brady. 1998. A role for cyclin-dependent ki-
nase(s) in the modulation of fast anterograde axonal transport: effects de-
fined by olomoucine and the APC tumor suppressor protein. J. Neurosci. 18:
7717–7726.
Riederer, B.M., and L.I. Binder. 1994. Differential distribution of tau proteins in
developing cat cerebellum. Brain Res. Bull. 33:155–161.
Rogers, S.L., and V.I. Gelfand. 2000. Membrane trafficking, organelle transport,
and the cytoskeleton. Curr. Opin. Cell Biol. 12:57–62.
Roy, S., P. Coffee, G. Smith, R.K. Liem, S.T. Brady, and M.M. Black. 2000. Neu-
rofilaments are transported rapidly but intermittently in axons: implications
for slow axonal transport. J. Neurosci. 20:6849–6861.
Sato-Harada, R., S. Okabe, T. Umeyama, Y. Kanai, and N. Hirokawa. 1996. Mi-
crotubule-associated proteins regulate microtubule function as the track for
intracellular membrane organelle transports. Cell Struct. Funct. 21:283–295.
Savaskan, N.E., and R. Nitsch. 2001. Molecules involved in reactive sprouting in
the hippocampus. Rev. Neurosci. 12:195–215.
Setou, M., T. Nakagawa, D.H. Seog, and N. Hirokawa. 2000. Kinesin superfamily
motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle
transport. Science. 288:1796–1802.
Shea, T.B., and L.A. Flanagan. 2001. Kinesin, dynein and neurofilament transport.
Trends Neurosci. 24:644–648.
Sheetz, M.P., K.K. Pfister, J.C. Bulinski, and C.W. Cotman. 1998. Mechanisms of
trafficking in axons and dendrites: implications for development and neuro-
degeneration. Prog. Neurobiol. 55:577–594.
Simons, M., E. Ikonen, P.J. Tienari, A. Cid-Arregui, U. Monning, K. Beyreuther,
and C.G. Dotti. 1995. Intracellular routing of human amyloid protein pre-
cursor: axonal delivery followed by transport to the dendrites. J. Neurosci.
Res. 41:121–128.
Sontag, E., V. Nunbhakdi-Craig, G. Lee, R. Brandt, C. Kamibayashi, J. Kuret,
C.L. White III, M.C. Mumby, and G.S. Bloom. 1999. Molecular interac-
tions among protein phosphatase 2A, tau, and microtubules. Implications
for the regulation of tau phosphorylation and the development of tauopa-
thies. J. Biol. Chem. 274:25490–25498.
Takei, Y., J. Teng, A. Harada, and N. Hirokawa. 2000. Defects in axonal elonga-
tion and neuronal migration in mice with disrupted tau and map1b genes. J.
Cell Biol. 150:989–1000.
Terry, R.D. 1998. The cytoskeleton in Alzheimer disease. J. Neural Transm. Suppl.
53:141–145.
Thinakaran, G., D.B. Teplow, R. Siman, B. Greenberg, and S.S. Sisodia. 1996.
Metabolism of the “Swedish” amyloid precursor protein variant in neuro2a
(N2a) cells. Evidence that cleavage at the “beta-secretase” site occurs in the
golgi apparatus. J. Biol. Chem. 271:9390–9397.
Trinczek, B., A. Ebneth, E.M. Mandelkow, and E. Mandelkow. 1999. Tau regu-
lates the attachment/detachment but not the speed of motors in microtu-
bule-dependent transport of single vesicles and organelles. J. Cell Sci. 112:
2355–2367.
Verhey, K.J., D. Meyer, R. Deehan, J. Blenis, B.J. Schnapp, T.A. Rapoport, and B.
Margolis. 2001. Cargo of kinesin identified as JIP scaffolding proteins and
associated signaling molecules. J. Cell Biol. 152:959–970.
Walter, J., B. Kern-Veits, J. Huf, B. Stolze, and F. Bonhoeffer. 1987. Recognition
of position-specific properties of tectal cell membranes by retinal axons in
vitro. Development. 101:685–696.
Wang, L., C.L. Ho, D. Sun, R.K. Liem, and A. Brown. 2000. Rapid movement of
axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol.
2:137–141.
Wittmann, C.W., M.F. Wszolek, J.M. Shulman, P.M. Salvaterra, J. Lewis, M.
Hutton, and M.B. Feany. 2001. Tauopathy in Drosophila: neurodegenera-
tion without neurofibrillary tangles. Science. 293:711–714.
Xu, H., D. Sweeney, R. Wang, G. Thinakaran, A.C. Lo, S.S. Sisodia, P. Green-
gard, and S. Gandy. 1997. Generation of Alzheimer beta-amyloid protein in
the trans-Golgi network in the apparent absence of vesicle formation. Proc.
Natl. Acad. Sci. USA. 94:3748–3752.
Yabe, J.T., A. Pimenta, and T.B. Shea. 1999. Kinesin-mediated transport of neu-
rofilament protein oligomers in growing axons. J. Cell Sci. 112:3799–3814.
Zhou, H.M., I. Brust-Mascher, and J.M. Scholey. 2001. Direct visualization of the
movement of the monomeric axonal transport motor UNC-104 along neu-
ronal processes in living Caenorhabditis elegans. J. Neurosci. 21:3749–3755.